Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Collaboration › Details

Fulcrum Therapeutics–Morgan Stanley: investor conference, 201909 supply service Fulcrum presents at Morgan Stanley Global Healthcare Conference NY

 

Period Period 2019-09-11
Region Region New York, NY
  Country United States (USA)
Organisations Partner, 1st Fulcrum Therapeutics Inc. (Nasdaq: FULC)
  Partner, 2nd Morgan Stanley & Co. LLC
  Group Morgan Stanley (Group)
Products Product Morgan Stanley Global Healthcare Conference 2019 New York
  Product 2 losmapimod
Persons Person Tartaglia, Christina (Stern IR 201809)
  Person 2 Green, Sara (Ten Bridge Communications 201908)
     

Fulcrum Therapeutics, Inc.. (9/3/19). "Press Release: Fulcrum Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference". Cambridge, MA.

Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that members of the management team will provide a business overview and update at the Morgan Stanley 17th Annual Global Healthcare Conference at 8:45 a.m. ET on Wednesday, September 11, 2019 in New York, NY.

A live webcast of the presentation will be available through the investor relations section of the Company's website at www.fulcrumtx.com. Following the live webcast, an archived replay will be available on the Company's website.


About Fulcrum Therapeutics

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. Fulcrum’s proprietary product engine identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. Please visit www.fulcrumtx.com.


Investor Contact:
Christina Tartaglia
Stern Investor Relations, Inc.
212.362.1200
christina@sternir.com

Media Contact:
Sara Green
Ten Bridge Communications
sgreen@tenbridgecommunications.com
617-233-1714

   
Record changed: 2019-09-07

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Fulcrum Therapeutics Inc. (Nasdaq: FULC)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2019 Hamburg Germany BEU2019 650x80px




» top